We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new ...
Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound. Here's how we reported it.
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...